The pharmaceutical company JSC Biolik (Kharkiv) confirmed that on December 31, 2020, it submitted an application to the Ministry of Health of Ukraine for registration of the Sputnik V vaccine against COVID-19 developed in Russia.
“In connection with numerous inquiries, the administration of JSC Biolik informs that on December 31, 2020 we did send to the Ministry of Health of Ukraine an application for state registration of a medicinal product – vaccine Gam-COVID-Vac, combined vector vaccine for the prevention of coronavirus infection caused by SARS-CoV-2 virus, produced by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Federation,” the company’s press service said.
The text of the statement was also made public.
As reported, earlier, head of the political council of the Opposition Platform – For Life party Viktor Medvedchuk said that on December 30, the Biolik pharmaceutical company applied to the Ministry of Health of Ukraine and the State Expert Center of the Ministry of Health with an application for state registration of the Sputnik V coronavirus vaccine.
On January 4, the State Expert Center, with reference to its head Mykhailo Babenko, told Interfax-Ukraine that “as of 11:00 of January 4, 2021, the State Expert Center didn’t receive applications for registration of any vaccines against COVID-19 from the company Biolik.
The Sputnik V vaccine has not passed the third phase of clinical trials.
In turn, Deputy Minister of Health, Chief Sanitary Doctor of Ukraine Viktor Liashko assured that only those vaccines against coronavirus infection that have successfully completed clinical trials will be used in Ukraine, “therefore, all rumors and political statements about the state registration of the Russian vaccine candidate in Ukraine do not correspond to reality.” Liashko said that according to available data, the completion of the third phase of clinical trials of the Sputnik V vaccine is scheduled for December 2021.
In early December, the Russian Direct Investment Fund announced readiness of JSC Biolik (Kharkiv) to produce the Russian Sputnik V vaccine against COVID-19 in Ukraine. At the same time, Biolik company denied that statement then.
The international investment company Millstone & Co with offices in Ukraine and Poland has become a co-owner of Prydniprovska BioTES LLC (Kyiv) with a 25% share of the authorized capital and intends to increase it to 50%, the company said on Tuesday with reference to Senior Project Manager of Millstone & Co Andriy Bozhenko.
“At the first stage, which already took place at the end of last year, 2020, we received 25%, and after the decision of the Antimonopoly Committee of Ukraine we will receive another 25%,” he said, commenting on the agreement, which provides for two stages of Millstone & Co’s entry into the authorized capital of Prydniprovska BioTES.
In the public register, the owners of Prydniprovska BioTES are Ihor Tynny investing in renewable energy sources with 5.67% and the Memphis venture fund of his father Vladyslav Tynny with 10%, venture funds Avant and Accent of developer Ihor Nikonov with 20%, Oleh Boiko (through Finance Elite Company LLC) with 25.1%, DATE Investment Management Limited (Cyprus) with 24.9% and Hanna Popruha with 13.33%.
Bozhenko said that investments in the construction of a new thermal power plant in Tokmak, Zaporizhia region with a total power generation capacity of 8.6 MW and heat energy of 28 MW were almost EUR 10 million, half of which came from Millstone & Co. By the time the plant is put into operation, it is planned to invest another EUR 3-4 million, he said.
According to Millstone & Co, the TPP will start operating in the second half of this year.
Millstone & Co is a private investment company providing investment services to clients. It has offices in Warsaw, Krakow and Kyiv.
Retail turnover in Ukraine by regions in Jan-Oct 2020 (UAH MLN).
The Cabinet of Ministers of Ukraine has introduced changes to decree of December 9, 2020 No. 1236 “On the establishment of quarantine and the introduction of restrictive anti-epidemic measures in order to prevent the spread in Ukraine of the acute respiratory disease COVID-19 caused by the SARS-CoV-2 coronavirus” that lax trade.
Corresponding decree of January 5, 2021 No. 9 was published on the government website on Thursday evening.
In particular, according to the decree, the government allowed the sale of household chemicals, periodicals, collection and storage of waste.
The Cabinet of Ministers of Ukraine, as part of the implementation of presidential decree No.53 on the concept of combating terrorism in Ukraine dated March 5, 2019, approved a new action plan for the implementation of this concept, which refers to increased state control over the import, registration, production and use in the country of unmanned aircraft systems.
The relevant document was made public on the government website.
“To take measures to implement, within the competence, enhanced state control over the import, registration, production and use of unmanned aircraft systems in Ukraine in order to prevent the use of such systems for terrorist purposes,” the Cabinet of Ministers said in the plan. According to the text of the document, these measures were instructed to be carried out by the State Customs Service, the State Aviation Administration, the State Border Guard Service, the Ministry of Defense, the Ministry of Internal Affairs, the Security Service of Ukraine (by agreement), the Foreign Intelligence Service (by agreement), the Economy Ministry, and other interested public agencies (by agreement).
Map of internet coverings of basic mobile operators.
